Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway

J Cell Mol Med. 2021 Jul;25(14):6664-6678. doi: 10.1111/jcmm.16670. Epub 2021 Jun 11.

Abstract

Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF-κB signalling and reduced the production of pro-inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF-κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti-inflammatory effect of PAB and rescue the activation of NF-κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF-κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA.

Keywords: NF-κB signalling; Osteoarthritis; PPARγ; pseudolaric acid B.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Vessels / drug effects
  • Blood Vessels / growth & development
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / growth & development
  • Cartilage, Articular / pathology
  • Chondrocytes / drug effects
  • Disease Models, Animal
  • Diterpenes / pharmacology*
  • Humans
  • Inflammation / drug therapy
  • Inflammation / genetics
  • Inflammation / parasitology
  • Mice
  • NF-kappa B / genetics
  • Osteoarthritis / drug therapy*
  • Osteoarthritis / genetics
  • Osteoarthritis / pathology
  • PPAR gamma / genetics*
  • RAW 264.7 Cells
  • Signal Transduction / drug effects
  • Synovitis / drug therapy*
  • Synovitis / genetics
  • Synovitis / pathology
  • Transcription Factor RelA / genetics

Substances

  • Diterpenes
  • NF-kappa B
  • PPAR gamma
  • Pparg protein, mouse
  • Rela protein, mouse
  • Transcription Factor RelA
  • pseudolaric acid B